The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Effects of Long-Term Atomoxetine Treatment for Young Children With Attention-Deficit/Hyperactivity Disorder
Abstract
Objective The purpose of this 13-study (seven double-blind/placebo-controlled, six open-label) meta-analysis is to determine the effectiveness and tolerability of long-term atomoxetine treatment among young children with attention-deficit/hyperactivity disorder (ADHD).Method Data were pooled from 6- and 7-year-olds (N = 272) who met DSM-IV criteria for ADHD, received atomoxetine treatment, and were enrolled in clinical trials of > or =2 years. Of these, 97 subjects reached the 24-month time point, providing data for long-term trend analysis of safety and effectiveness.Results Effectiveness for most subjects was maintained over long-term treatment, as demonstrated by total scores and total T scores on the Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version, investigator administered and scored. During the 2-year period, 25.7% discontinued because of lack of effectiveness, but adverse events were clinically minor and transient, and only 4.0% of children discontinued because of an adverse event. Notable effects on growth were seen during early phases of the study, with attenuation occurring by the 2-year time point. Statistically significant increases in pulse and blood pressure and decreases in cardiac PR interval were seen, but no changes were deemed both statistically significant and clinically meaningful among any vital signs, electrocardiographic measures, or laboratory tests.Conclusion Long-term atomoxetine treatment appears generally well tolerated and effective in the treatment of young children with ADHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Efficacy of both methylphenidate and atomoxetine has been established in placebo controlled trials [12-15].”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766
(1976) · Medical Entomology and Zoology · Cited by 8,899
CDC growth charts: United States.
Kuczmarski, R. J., Ogden, C. L., Grummer‐Strawn, L. M., Flegal, K. M., Guo, S. S., Wei, R. X., Mei, Z., Curtin, L. R., Roche, A. F., & Johnson, C. L. (2000) · PubMed · Cited by 5,298
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
(1998) · Cited by 2,026
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738
Report of the Second Task Force on Blood Pressure Control in Children—1987
Task Force on Blood Pressure Control in Children (1987) · PEDIATRICS · doi:10.1542/peds.79.1.1 · Cited by 1,149
Report of the second Task Force on Blood Pressure Control in Children―1987
Horan, M. J. (1987) · PEDIATRICS · Cited by 1,127
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Research works printed but not linked: 6
- Allen, 2002, Safety and efficacy of atomoxetine in pediatric CYP2D6 extensive vs. poor metabolizers, Biol Psychiatry, 51, 37S
- Spencer TJ (2003), Treatment for ADHD with OROS methylphenidate: long-term effect on growth. Proceedings Summary of the 156th Annual Meeting of the American Psychiatric Association, San Francisco, May 17-22, p 268
- Sutton V, Milton D, Ruff D, Allen AJ (2004a), Atomoxetine efficacy over time in children and adolescents with ADHD. In: Scientific Proceedings of the 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington, D C, October 19-24, p 157
- Sutton V, Milton D, Ruff D, Allen AJ (2004b), Long term effects of atomoxetine on growth in children with ADHD. In: Scientific Proceedings of the 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington, DC, October 19-24, p 132
- Wernicke JF, Kratochvil C, Milton D et al. (2002), Long-term safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder. In: Proceedings Summary of the 155th Annual Meeting of the American Psychiatric Association, Philadelphia, May 18-23, p 92
- Wigal SB, Steinhoff K, McGough JJ et al. (2004), Analog classroom study of amphetamine XR and atomoxetine for ADHD. In: Scientific Proceedings of the 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington, DC, October 19-24, p 135
Cited by
Sorted by citations
Garnock-Jones, K. P., & Keating, G. M. (2009) · Pediatric Drugs · doi:10.2165/00148581-200911030-00005 · Cited by 392
Robinson, E. S. J., Eagle, D. M., Mar, A. C., Bari, A., Banerjee, G., Jiang, X., Dalley, J. W., & Robbins, T. W. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301487 · Cited by 359
Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder
Cortese, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1917069 · Cited by 342
Cortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Graham, J., Taylor, E., Sergeant, J., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12036 · Cited by 336
Stiefel, G., & Besag, F. (2010) · Drug Safety · doi:10.2165/11536380-000000000-00000 · Cited by 256
Metadata
- Authors
- KRATOCHVIL, C. J., WILENS, T. E., GREENHILL, L. L., GAO, H., BAKER, K. D., FELDMAN, P. D., & GELOWITZ, D. L.
- Affiliations
- Harvard University (US)
- Corresponding author
- KRATOCHVIL, CHRISTOPHER J.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 45
- Issue
- 8
- Pages
- 919-927
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W1965946834
- Cited by
- 150
- References
- 37
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 6 · 2016: 6 · 2015: 9 · 2014: 9 · 2013: 10 · 2012: 6
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Keywords
- atomoxetine, attention deficit hyperactivity disorder, young children, long-term treatment, treatment effectiveness, tolerability, adverse events, growth, blood pressure, pulse rate, ADHD Rating Scale-IV
- MeSH terms
- Atomoxetine Hydrochloride, Attention Deficit Disorder with Hyperactivity, Child, Female, Humans, Male, Propylamines, Time Factors, Adrenergic Uptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
